Use of Intravenous Lidocaine, Ketamine, and Magnesium for Acute Pain Control After Lung Resection Surgery: A Prospective Cohort Study.

Background

Thoracic surgery is associated with severe postoperative pain caused by chest wall manipulation and intercostal nerve injury. Multimodal analgesia with non-opioid agents such as lidocaine, ketamine and magnesium might be beneficial for pain control and reduce opioid consumption.

Methods

In this prospective cohort study, we recruited 118 consecutive patients who underwent lung resection via thoracotomy from January 2019 to January 2021 at Hospital Universitari de Girona Doctor Josep Trueta. The primary outcome was total intravenous morphine consumption within the first 24 h postoperatively. Multivariable linear regression modeling was used to determine the adjusted association between lidocaine, ketamine and magnesium administration and morphine consumption in the first 24 h after surgery. Statistical analysis was performed using Wilcoxon's rank-sum and Fisher's exact tests.

Results

In total, 71 patients received lidocaine, ketamine and magnesium intraoperatively (LKM group) while 47 patients did not receive this regimen (non-LKM group). The LKM group had a higher prevalence of hypertension and higher proportions of patients undergoing lobectomy and pneumonectomy. Morphine consumption within 24 h postoperatively was lower in the LKM group than in the non-LKM group (median (interquartile range), 2 (0-6) mg vs. 5 (3-8) mg; p = 0.001). No drug-related adverse events were observed. After multivariable risk adjustment, lidocaine, ketamine and magnesium use was associated with significantly decreased total intravenous morphine consumption within 24 h postoperatively (-1.76, 95% confidence interval = -3.40 to -0.12, p = 0.03).

Conclusions

Lidocaine, ketamine and magnesium use was associated with lower 24 h morphine consumption in our prospective cohort.